Multimodal multiphasic preoperative image-based deep-learning predicts HCC outcomes after curative surgery

肝细胞癌 队列 医学 接收机工作特性 放射科 内科学
作者
Rex Wan‐Hin Hui,K.W. Chiu,I‐Cheng Lee,Chenlu Wang,Ho Ming Cheng,Jian‐Liang Lu,Xianhua Mao,Sarah N. Yu,Lok-Ka Lam,Lung‐Yi Mak,Tan To Cheung,Nam-Hung Chia,Chin‐Cheung Cheung,W. Kan,Tiffany Wong,Albert Chan,Yi-Hsiang Huang,Man‐Fung Yuen,Philip L. H. Yu,Wai‐Kay Seto
出处
期刊:Hepatology [Lippincott Williams & Wilkins]
卷期号:82 (2): 344-356 被引量:14
标识
DOI:10.1097/hep.0000000000001180
摘要

BACKGROUND AND AIMS: HCC recurrence frequently occurs after curative surgery. Histological microvascular invasion (MVI) predicts recurrence but cannot provide preoperative prognostication, whereas clinical prediction scores have variable performances. APPROACH AND RESULTS: Recurr-NET, a multimodal multiphasic residual-network random survival forest deep-learning model incorporating preoperative CT and clinical parameters, was developed to predict HCC recurrence. Preoperative triphasic CT scans were retrieved from patients with resected histology-confirmed HCC from 4 centers in Hong Kong (internal cohort). The internal cohort was randomly divided in an 8:2 ratio into training and internal validation. External testing was performed in an independent cohort from Taiwan.Among 1231 patients (age 62.4y, 83.1% male, 86.8% viral hepatitis, and median follow-up 65.1mo), cumulative HCC recurrence rates at years 2 and 5 were 41.8% and 56.4%, respectively. Recurr-NET achieved excellent accuracy in predicting recurrence from years 1 to 5 (internal cohort AUROC 0.770-0.857; external AUROC 0.758-0.798), significantly outperforming MVI (internal AUROC 0.518-0.590; external AUROC 0.557-0.615) and multiple clinical risk scores (ERASL-PRE, ERASL-POST, DFT, and Shim scores) (internal AUROC 0.523-0.587, external AUROC: 0.524-0.620), respectively (all p < 0.001). Recurr-NET was superior to MVI in stratifying recurrence risks at year 2 (internal: 72.5% vs. 50.0% in MVI; external: 65.3% vs. 46.6% in MVI) and year 5 (internal: 86.4% vs. 62.5% in MVI; external: 81.4% vs. 63.8% in MVI) (all p < 0.001). Recurr-NET was also superior to MVI in stratifying liver-related and all-cause mortality (all p < 0.001). The performance of Recurr-NET remained robust in subgroup analyses. CONCLUSIONS: Recurr-NET accurately predicted HCC recurrence, outperforming MVI and clinical prediction scores, highlighting its potential in preoperative prognostication.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
宇森发布了新的文献求助10
刚刚
英姑应助瓒ZAN采纳,获得10
1秒前
斗罗大陆完成签到,获得积分10
2秒前
SciGPT应助小小琳采纳,获得10
2秒前
shang完成签到,获得积分10
3秒前
hz发布了新的文献求助10
3秒前
Jasper应助Zhang采纳,获得10
3秒前
leeeeeeee完成签到 ,获得积分10
3秒前
cc完成签到,获得积分10
4秒前
英勇半烟发布了新的文献求助10
4秒前
ding应助Nina采纳,获得10
5秒前
Akim应助向晨采纳,获得10
5秒前
曼波哈基米完成签到,获得积分10
5秒前
实验室应助打开天窗说亮话采纳,获得200
5秒前
6秒前
田様应助阿黄与小橘采纳,获得10
6秒前
HooBea发布了新的文献求助10
6秒前
8秒前
8秒前
laber应助科研通管家采纳,获得50
9秒前
烟花应助缥缈幻悲采纳,获得10
9秒前
形成完成签到,获得积分10
9秒前
在水一方应助科研通管家采纳,获得10
9秒前
meixinhu完成签到,获得积分10
9秒前
隐形曼青应助科研通管家采纳,获得20
9秒前
wanci应助科研通管家采纳,获得10
9秒前
鸽子应助科研通管家采纳,获得10
9秒前
9秒前
茄咪完成签到,获得积分20
9秒前
10秒前
lmq完成签到,获得积分10
10秒前
东方元语应助科研通管家采纳,获得20
10秒前
SciGPT应助科研通管家采纳,获得10
10秒前
田様应助科研通管家采纳,获得10
10秒前
10秒前
Zhang完成签到,获得积分20
10秒前
所所应助科研通管家采纳,获得10
10秒前
11秒前
woshi123应助科研通管家采纳,获得10
11秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Römisch-Germanische Forschungen 1000
China Pluperfect I: Epistemology of Past and Outside in Chinese Art 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
The fast track to determining transfer functions of linear circuits: The student guide 500
The Analytical and Numerical Solution of Electric and Magnetic Fields 500
Green Fire Retardants for Polymeric Materials 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7617449
求助须知:如何正确求助?哪些是违规求助? 9192715
关于积分的说明 19701181
捐赠科研通 7189656
什么是DOI,文献DOI怎么找? 3272003
关于科研通互助平台的介绍 2434795
邀请新用户注册赠送积分活动 2267112